The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma.
Gauvreau GM, Becker AB, Boulet LP, Chakir J, Fick RB, Greene WL, Killian KJ, O'byrne PM, Reid JK, Cockcroft DW.
J Allergy Clin Immunol. 2003 Aug;112(2):331-8.PMID: 12897739 [PubMed - indexed for MEDLINE]Related articles